Report : Middle East & Africa Prefilled Syringe Market Forecast to 2030 - Regional Analysis - by Type (Disposable Prefilled Syringes and Reusable Prefilled Syringes), Material (Glass Prefilled Syringes and Plastic Prefilled Syringes), Design (Single Chamber and Multi-chamber), Application (Cancer, Diabetes, Autoimmune Disease, Infectious diseases, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel)
At 9.0% CAGR, Middle East & Africa Prefilled Syringe Market is Speculated to be Worth US$ 404.57 Million by 2030, Says Business Market Insights
According to Business Market Insights' research, the Middle East & Africa prefilled syringe market was valued at US$ 202.76 million in 2022 and is expected to reach US$ 404.57 million by 2030, registering a CAGR of 9.0% from 2022 to 2030. Increasing prevalence of chronic disorders and growing adoption of self-injecting parenteral devices are among the critical factors attributed to the Middle East & Africa prefilled syringe market expansion.
The growing aging population and changes in social behavior and lifestyle contribute to some of the common long-term health conditions. As per the World Health Organization (WHO), the prevalence of chronic lifestyle diseases is expected to increase by 57% by the end of 2026. The emerging markets will be hit hardest, as a population explosion is expected in developing countries. With the increasing urbanization, people are more inclined toward a sedentary lifestyle, which results in rheumatoid arthritis, diabetes, and others. Diabetes is one of the major global health issues of the 21st century.
Other chronic conditions such as Crohn's disease, multiple sclerosis, and cardiovascular disorders require frequent drug administration for disease management and treatment. As per the WHO, cardiovascular disorders are the leading cause of death-nearly 17.9 million deaths are reported every year due to cardiovascular disorders. It has become a new standard for injectable drug delivery among large patient populations globally. Moreover, these prefilled syringes can be used by a large patient population with minimal training and do not require constant assistance from healthcare professionals, owing to which prefilled syringes are adopted largely in professional healthcare environments as well as home healthcare settings, thereby driving the prefilled syringes market growth.
On the contrary, increasing product recalls hampers the growth of Middle East & Africa prefilled syringe market.
Based on type, the Middle East & Africa prefilled syringe market is bifurcated into disposable prefilled syringes and reusable prefilled syringes. The disposable prefilled syringes segment held 72.3% share of the Middle East & Africa prefilled syringe market in 2022, amassing US$ 146.63 million. It is projected to garner US$ 298.92 million by 2030 to expand at 9.3% CAGR during 2022-2030.
In terms of material, the Middle East & Africa prefilled syringe market is bifurcated into glass prefilled syringes and plastic prefilled syringes. The glass prefilled syringes segment held 59.0% share of the Middle East & Africa prefilled syringe market in 2022, amassing US$ 119.61 million. It is projected to garner US$ 234.20 million by 2030 to expand at 8.8% CAGR during 2022-2030.
Based on designs, the Middle East & Africa prefilled syringe market is bifurcated into single chamber and multi chamber. The single chamber segment held 67.9% share of the Middle East & Africa prefilled syringe market in 2022, amassing US$ 137.72 million. It is projected to garner US$ 253.85 million by 2030 to expand at 7.9% CAGR during 2022-2030.
In terms of application, the Middle East & Africa prefilled syringe market is segmented into cancer, diabetes, autoimmune disease, infectious diseases, and others. The others segment held 30.0% share of the Middle East & Africa prefilled syringe market in 2022, amassing US$ 60.83 million. It is projected to garner US$ 116.37 million by 2030 to expand at 8.4% CAGR during 2022-2030.
By distribution channel, the Middle East & Africa prefilled syringe market is segmented into hospital pharmacy, retail pharmacy, and online channel. The hospital pharmacy segment held 55.7% share of Middle East & Africa prefilled syringe market in 2022, amassing US$ 112.96 million. It is projected to garner US$ 233.24 million by 2030 to expand at 9.5% CAGR during 2022-2030.
Based on country, the Middle East & Africa prefilled syringe market is categorized into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. The Rest of Middle East & Africa held 28.3% share of Middle East & Africa prefilled syringe market in 2022, amassing US$ 57.42 million. It is projected to garner US$ 106.89 million by 2030 to expand at 8.1% CAGR during 2022-2030.
Key players operating in the Middle East & Africa prefilled syringe market are B Braun SE, Shandong Weigao Group Medical Polymer Co Ltd, Schott AG, Nipro Corp, Becton Dickinson and Co, Baxter International Inc, Terumo Corp, and Ypsomed Holding AG, among others.
- In May 2023, BD increased customer access to an all-in-one prefilled flush syringe with an integrated disinfection unit meant to reinforce infection prevention principles and streamline nurse workflow. The BD PosiFlush SafeScrub is a prefilled saline flush syringe with an active disinfection unit incorporated straight into the tip cap that has been shown in vitro to drastically minimise bacteria growth associated with CRBSIs.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com